These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33498177)

  • 1. Inflammatory Bowel Disease: New Insights into the Interplay between Environmental Factors and PPARγ.
    Caioni G; Viscido A; d'Angelo M; Panella G; Castelli V; Merola C; Frieri G; Latella G; Cimini A; Benedetti E
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases.
    Venkataraman B; Ojha S; Belur PD; Bhongade B; Raj V; Collin PD; Adrian TE; Subramanya SB
    Phytother Res; 2020 Jul; 34(7):1530-1549. PubMed ID: 32009281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation.
    Venkataraman B; Almarzooqi S; Raj V; Bhongade BA; Patil RB; Subramanian VS; Attoub S; Rizvi TA; Adrian TE; Subramanya SB
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin 2 links inflammation and ankylosis in the clinical overlap of inflammatory bowel disease (IBD) and ankylosing spondylitis (AS).
    Lin A; Inman RD; Streutker CJ; Zhang Z; Pritzker KPH; Tsui HW; Tsui FWL
    Arthritis Res Ther; 2020 Mar; 22(1):51. PubMed ID: 32188494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial imbalance and gut pathologies: Association and contribution of E. coli in inflammatory bowel disease.
    Khan S; Imran A; Malik A; Chaudhary AA; Rub A; Jan AT; Syed JB; Rolfo C
    Crit Rev Clin Lab Sci; 2019 Jan; 56(1):1-17. PubMed ID: 30373492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration.
    Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Grimm MC
    Public Health Rev; 2021; 42():1603990. PubMed ID: 34692176
    [No Abstract]   [Full Text] [Related]  

  • 9. Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future.
    Oliveira ECS; Quaglio AEV; Magro DO; Di Stasi LC; Sassaki LY
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases.
    Decara J; Rivera P; López-Gambero AJ; Serrano A; Pavón FJ; Baixeras E; Rodríguez de Fonseca F; Suárez J
    Front Pharmacol; 2020; 11():730. PubMed ID: 32536865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common PPARγ variants C161T and Pro12Ala are not associated with inflammatory bowel disease in an Australian cohort.
    Hume GE; Fowler EV; Griffiths LR; Doecke JD; Radford-Smith GL
    J Gastrointestin Liver Dis; 2012 Dec; 21(4):349-55. PubMed ID: 23256116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor γ 2 mutation may cause a subset of ulcerative colitis.
    Aoyagi Y; Nagata S; Kudo T; Fujii T; Wada M; Chiba Y; Ohtsuka Y; Yamashiro Y; Shimizu T; Ohkusa T
    Pediatr Int; 2010 Oct; 52(5):729-34. PubMed ID: 20591056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease.
    Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B
    Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.
    Andersen V; Christensen J; Ernst A; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
    World J Gastroenterol; 2011 Jan; 17(2):197-206. PubMed ID: 21245992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
    Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
    Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease: between genetics and microbiota.
    Younis N; Zarif R; Mahfouz R
    Mol Biol Rep; 2020 Apr; 47(4):3053-3063. PubMed ID: 32086718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease.
    Atug O; Tahan V; Eren F; Tiftikci A; Imeryuz N; Hamzaoglu HO; Tozun N
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):433-7. PubMed ID: 19104705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort.
    Poliska S; Penyige A; Lakatos PL; ; Papp M; Palatka K; Lakatos L; Molnar T; Nagy L
    Inflamm Bowel Dis; 2012 Mar; 18(3):472-9. PubMed ID: 21710534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)].
    Rousseaux C; Desreumaux P
    J Soc Biol; 2006; 200(2):121-31. PubMed ID: 17151549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of IBD Heritability: Genes, Bugs, and More.
    Turpin W; Goethel A; Bedrani L; Croitoru Mdcm K
    Inflamm Bowel Dis; 2018 May; 24(6):1133-1148. PubMed ID: 29701818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.